sIL2-Fc-sIL13 (Medicenna Therapeutics)

N/A

Report date: 2026/01/06 10:17:09
NME

Base Information

Drug NamesIL2-Fc-sIL13 (Medicenna Therapeutics)
Drug Alias NameBispecific IL-2/IL-13 superkine (Medicenna Therapeutics)sIL2M-Fc-sIL13MBiSKITs™MDNA-19-MDNA-413MDNA19-MDNA413
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokines
Mechanisms of ActionInterleukin-13 inhibitorsInterleukin-2 stimulants
TargetsInterleukin-2Interleukin-13
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMedicenna Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesMedicenna Therapeutics
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A